Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus

Cymbaria daurica L. has a long history as a folk medicine and tea for the treatment of diabetes. However, the biological activity and mechanism of its hypoglycemic effect have not been fully elucidated. In this study, the potential mechanism of C. daurica against type 2 diabetes mellitus (T2DM) was...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruyu Shi, Dongxue Chen, Mingyue Ji, Baochang Zhou, Ziyan Zhang, Chunhong Zhang, Minhui Li
Format: Article
Language:English
Published: Tsinghua University Press 2023-11-01
Series:Food Science and Human Wellness
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213453023000745
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557802388717568
author Ruyu Shi
Dongxue Chen
Mingyue Ji
Baochang Zhou
Ziyan Zhang
Chunhong Zhang
Minhui Li
author_facet Ruyu Shi
Dongxue Chen
Mingyue Ji
Baochang Zhou
Ziyan Zhang
Chunhong Zhang
Minhui Li
author_sort Ruyu Shi
collection DOAJ
description Cymbaria daurica L. has a long history as a folk medicine and tea for the treatment of diabetes. However, the biological activity and mechanism of its hypoglycemic effect have not been fully elucidated. In this study, the potential mechanism of C. daurica against type 2 diabetes mellitus (T2DM) was postulated via pharmacological network analysis. Based on data mining techniques involving topological parameters, gene ontology, and pathway enrichment, we established a compound-target, protein-protein interaction, and target-pathway network to identify central targets and pathways. Pathway enrichment analysis revealed that the most important pathway associated with C. daurica in treating T2DM is the PI3K-Akt signaling pathway. Molecular docking was performed to validate the predicted results. Then, a HepG2 cell insulin resistance model and a high-fat, high-glucose diet combined with a streptozotocin-induced T2DM rat model was established to assess the fasting glucose changes and lipid profile after C. daurica treatment, respectively. Finally, real-time PCR and western blotting were used to verify changes in key targets. The anti-diabetic mechanism of the active ingredient in C. daurica may involve the regulation of IRS-2, Akt1, GLUT4, and GSK3β.
format Article
id doaj-art-efebbe73677b4a428b4e16241a6d6cde
institution Kabale University
issn 2213-4530
language English
publishDate 2023-11-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-efebbe73677b4a428b4e16241a6d6cde2025-02-03T02:42:14ZengTsinghua University PressFood Science and Human Wellness2213-45302023-11-0112620012013Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitusRuyu Shi0Dongxue Chen1Mingyue Ji2Baochang Zhou3Ziyan Zhang4Chunhong Zhang5Minhui Li6Inner Mongolia Hospital of Traditional Chinese Medicine, Hohhot 010020, China; Inner Mongolia Key Laboratory of Characteristic Geoherbs Resources Protection and Utilization, Baotou Medical College, Baotou 014040, ChinaInner Mongolia Hospital of Traditional Chinese Medicine, Hohhot 010020, China; Inner Mongolia Institute of Traditional Chinese Medicine, Hohhot 010020, ChinaInner Mongolia Key Laboratory of Characteristic Geoherbs Resources Protection and Utilization, Baotou Medical College, Baotou 014040, China; Inner Mongolia Engineering Research Center of the Planting and Development of Astragalus membranaceus of the Geoherbs, Baotou Medical College, Baotou 014040, ChinaInner Mongolia Hospital of Traditional Chinese Medicine, Hohhot 010020, China; Inner Mongolia Institute of Traditional Chinese Medicine, Hohhot 010020, ChinaInner Mongolia Hospital of Traditional Chinese Medicine, Hohhot 010020, China; Inner Mongolia Institute of Traditional Chinese Medicine, Hohhot 010020, ChinaInner Mongolia Engineering Research Center of the Planting and Development of Astragalus membranaceus of the Geoherbs, Baotou Medical College, Baotou 014040, China; Inner Mongolia Key Laboratory of Chinese Medicine Resources, Baotou Medical College, Baotou 014040, China; Corresponding authors.Inner Mongolia Hospital of Traditional Chinese Medicine, Hohhot 010020, China; Inner Mongolia Key Laboratory of Characteristic Geoherbs Resources Protection and Utilization, Baotou Medical College, Baotou 014040, China; Inner Mongolia Institute of Traditional Chinese Medicine, Hohhot 010020, China; Corresponding authors.Cymbaria daurica L. has a long history as a folk medicine and tea for the treatment of diabetes. However, the biological activity and mechanism of its hypoglycemic effect have not been fully elucidated. In this study, the potential mechanism of C. daurica against type 2 diabetes mellitus (T2DM) was postulated via pharmacological network analysis. Based on data mining techniques involving topological parameters, gene ontology, and pathway enrichment, we established a compound-target, protein-protein interaction, and target-pathway network to identify central targets and pathways. Pathway enrichment analysis revealed that the most important pathway associated with C. daurica in treating T2DM is the PI3K-Akt signaling pathway. Molecular docking was performed to validate the predicted results. Then, a HepG2 cell insulin resistance model and a high-fat, high-glucose diet combined with a streptozotocin-induced T2DM rat model was established to assess the fasting glucose changes and lipid profile after C. daurica treatment, respectively. Finally, real-time PCR and western blotting were used to verify changes in key targets. The anti-diabetic mechanism of the active ingredient in C. daurica may involve the regulation of IRS-2, Akt1, GLUT4, and GSK3β.http://www.sciencedirect.com/science/article/pii/S2213453023000745Cymbaria daurica L.Diabetes mellitusNetwork pharmacologyInsulin resistanceMolecular dockingPI3K-Akt signaling pathway
spellingShingle Ruyu Shi
Dongxue Chen
Mingyue Ji
Baochang Zhou
Ziyan Zhang
Chunhong Zhang
Minhui Li
Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus
Food Science and Human Wellness
Cymbaria daurica L.
Diabetes mellitus
Network pharmacology
Insulin resistance
Molecular docking
PI3K-Akt signaling pathway
title Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus
title_full Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus
title_fullStr Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus
title_full_unstemmed Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus
title_short Network pharmacology-based screening of the active ingredients and mechanisms of Cymbaria daurica against diabetes mellitus
title_sort network pharmacology based screening of the active ingredients and mechanisms of cymbaria daurica against diabetes mellitus
topic Cymbaria daurica L.
Diabetes mellitus
Network pharmacology
Insulin resistance
Molecular docking
PI3K-Akt signaling pathway
url http://www.sciencedirect.com/science/article/pii/S2213453023000745
work_keys_str_mv AT ruyushi networkpharmacologybasedscreeningoftheactiveingredientsandmechanismsofcymbariadauricaagainstdiabetesmellitus
AT dongxuechen networkpharmacologybasedscreeningoftheactiveingredientsandmechanismsofcymbariadauricaagainstdiabetesmellitus
AT mingyueji networkpharmacologybasedscreeningoftheactiveingredientsandmechanismsofcymbariadauricaagainstdiabetesmellitus
AT baochangzhou networkpharmacologybasedscreeningoftheactiveingredientsandmechanismsofcymbariadauricaagainstdiabetesmellitus
AT ziyanzhang networkpharmacologybasedscreeningoftheactiveingredientsandmechanismsofcymbariadauricaagainstdiabetesmellitus
AT chunhongzhang networkpharmacologybasedscreeningoftheactiveingredientsandmechanismsofcymbariadauricaagainstdiabetesmellitus
AT minhuili networkpharmacologybasedscreeningoftheactiveingredientsandmechanismsofcymbariadauricaagainstdiabetesmellitus